-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Phenotypic and Molecular Consequences of Noncoding TET2 Perturbations in the Human Hematopoietic System

Program: Special-Interest Sessions
Session: Promoting Minorities in Hematology (PMH) Oral Presentations: Room I (for in-person participants)
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 9, 2023, 6:30 PM-8:00 PM

Tre Artis

Harvard University, Cambridge, MA

Disclosures: No relevant conflicts of interest to declare.

See more of: Promoting Minorities in Hematology (PMH) Oral Presentations: Room I (for in-person participants)
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation